血糖測定器の世界市場

血糖測定器の世界市場は2030年までに米国で501億米ドルに達する見込み

2023年に318億米ドルと推定される血糖測定器の世界市場は、2030年には501億米ドルに達し、分析期間2023-2030年のCAGRは6.7％で成長すると予測されます。本レポートで分析したセグメントの1つであるセルフモニタリング血糖測定器は、CAGR 6.4％を記録し、分析期間終了までに368億米ドルに達すると予測されます。継続的な血糖測定器セグメントの成長率は、分析期間中CAGR 7.6%と推定されます。

米国市場は86億米ドルと推定、中国はCAGR 10.8％で成長予測

米国の血糖測定器市場は2023年に86億米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2023-2030年のCAGRを10.8%として、2030年までに市場規模が114億米ドルに達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ2.5％と7.0％と予測されています。欧州では、ドイツがCAGR 3.8%で成長すると予測されています。

世界の血糖測定器市場- 主要動向と促進要因のまとめ

なぜ血糖測定器は糖尿病管理に不可欠なのか？

血糖測定器は、血糖値を測定・監視するために設計されたコンパクトでポータブルな医療機器であり、糖尿病を管理する個人に重要な情報を提供します。血糖測定器の主なコンポーネントは、ランセットデバイス、テストストリップ、およびデジタルメーター自体です。まず、ランセットで指先を刺し、血液を一滴採取します。グルコースオキシダーゼやグルコースデヒドロゲナーゼのような酵素でコーティングされたストリップは、血液サンプルと反応し、血液中のグルコース濃度に比例した電気信号を発生します。この信号はメーターに送られ、メーターは地域の基準に応じて、1デシリットル当たりミリグラム（mg/dL）または1リットル当たりミリモル（mmol/L）で血糖値を計算し、表示します。最近の血糖測定器は、電気化学センサーや光学センサーなどの高度なバイオセンシング技術を使用して、測定の精度と速度を高め、多くの場合、数秒以内に結果を提供します。さらに、多くのメーターはメモリー保存、データ追跡、Bluetooth接続などの機能を備えており、ユーザーはグルコース測定値を保存し、ヘルスケア専門家と共有することで、より包括的な糖尿病管理を行うことができます。センサー技術と小型化の継続的な発展により、メーカーはより少量の血液サンプルで済むメーターを製造できるようになり、不快感を最小限に抑え、頻繁な検査をより便利なものにしています。

なぜ血糖測定器が糖尿病ケアに不可欠なのか？

血糖測定器は糖尿病ケアに不可欠です。なぜなら、血糖測定器は個人の血糖値をリアルタイムで把握することができ、糖尿病の状態を事前に管理し、合併症のリスクを減らすことができるからです。糖尿病は、インスリンの産生または利用障害を特徴とする慢性疾患であり、血糖値の上昇を招き、管理を怠ると心血管疾患、神経障害、腎臓障害、視力障害などの深刻な健康問題を引き起こす可能性があります。そのため、糖尿病患者にとって血糖値の定期的なモニタリングは、目標範囲を維持し、高血糖（高血糖）と低血糖（低血糖）の両方を予防するために不可欠です。血糖測定器は、ユーザーが自分のグルコースパターンを追跡し、食事摂取、身体活動、ストレス、投薬などの様々な要因が血糖値にどのように影響するかを理解する力を与えます。この知識により、インスリン投与量、食事の選択、生活習慣をタイムリーに調整することができ、より良い血糖コントロールを促進し、長期的な合併症の可能性を減らすことができます。さらに、血糖測定器は、インスリンの投与量やタイミングを微調整するために必要なデータを提供するため、集中的なインスリン治療を受けている患者にとって不可欠なものです。ヘルスケアプロバイダーにとって、これらのデバイスは、患者の経過をモニターし、治療計画に関してエビデンスに基づいた決定を下すための信頼できる手段を提供します。デジタル統合されたスマート・グルコース・メーターのイントロダクションは、これらの機器の役割をさらに強化し、グルコース・データをヘルスケア・チームとシームレスに共有し、遠隔医療イニシアチブをサポートすることを可能にしました。

どのような革新が血糖測定器の将来を形成しているのか？

最近の技術革新は、デバイスをより正確に、より低侵襲に、よりデジタルヘルスプラットフォームと統合させることで、血糖モニタリングの状況を変えつつあります。最も注目すべき進歩のひとつは、持続血糖モニタリング（CGM）システムの開発です。CGMシステムは、皮下に装着する小型センサーを使用して、昼夜を問わずリアルタイムのグルコース測定値を提供します。CGMシステムは、頻繁に指を刺す必要性をなくし、グルコース動向をより包括的に把握できるため、潜在的な高値・低値が発生する前にユーザーに警告を発します。さらに、従来の血糖測定器にスマートテクノロジーを統合することで、機能性とユーザーエクスペリエンスが向上しています。Bluetoothとクラウド接続を備えたスマートメーターにより、ユーザーは測定値をモバイルアプリに同期し、詳細な分析、傾向の視覚化、個人に合わせたフィードバックを提供できます。先進的なモデルの中には、グルコースデータを分析し、変動を予測する人工知能（AI）アルゴリズムを組み込んだものもあり、ユーザーが変化を予測し、それに応じて管理戦略を調整するのに役立っています。もう一つの画期的なイノベーションは、光学センサーや電磁分光法などの非侵襲的グルコースモニタリング技術の出現です。これらの技術は、採血を必要とせず、皮膚やその他の体液を通してグルコースレベルを測定することを目的としています。まだ開発途上ではあるが、これらの技術は、従来の検査法に伴う苦痛や不便さを大幅に軽減することで、血糖値モニタリングに革命をもたらすと期待されています。さらに、使い捨てのマイクロ針やレーザーベースのセンサーの使用は、採血の不快感を軽減できるとして注目を集めています。バイオセンサー技術の進歩により、ケトン体や乳酸のような追加バイオマーカーを測定できる多項目測定器も開発され、患者の代謝状態をより総合的に把握できるようになっています。

血糖値測定器市場の成長促進要因は？

血糖値測定器市場の成長は、糖尿病の世界の有病率の上昇、自己モニタリングの実践に対する意識の高まり、グルコースモニタリング技術の継続的な進歩など、いくつかの要因によってもたらされます。主な要因の一つは、糖尿病、特に2型糖尿病の罹患率の上昇であり、これは肥満、食生活の乱れ、運動不足などの生活習慣と関連しています。国際糖尿病連合によると、現在5億3,700万人以上の成人が糖尿病を患っており、この数は今後数十年で大幅に増加すると予想されています。定期的なモニタリングは糖尿病管理の要であるため、このような患者数の増加が効果的な血糖モニタリング・ソリューションの需要を促進しています。市場成長のもう一つの要因は、予防ヘルスケアと自己管理の重視の高まりです。各国政府やヘルスケア機関は、糖尿病教育プログラムの一環として血糖測定器の使用を推進し、早期発見とより良い疾病管理を奨励することで、ヘルスケアシステムの負担を軽減しています。スマートメーターや持続グルコースモニタリングシステムの開発などの技術的進歩も、グルコースモニタリングをより身近で正確、かつユーザーフレンドリーにすることで市場拡大を後押ししています。これらの機器は、自動データロギング、クラウドベースの共有、インスリンポンプとの統合などの機能を提供し、より包括的な糖尿病管理をサポートし、患者のアドヒアランスを向上させる。さらに、遠隔医療やデジタルヘルスプラットフォームの拡大により、遠隔モニタリングが糖尿病治療の一般的な要素となり、血糖測定器に新たなビジネスチャンスがもたらされています。さらに、新興市場における可処分所得の増加やヘルスケアインフラの改善により、先進的な血糖測定器がより手頃な価格となり、幅広い消費者層が利用できるようになっています。これらの地域では、グルコースメーターや検査ストリップの低価格モデルや償還政策のイントロダクションが、市場浸透をさらに後押ししています。これらの要因が相まって、血糖測定器の採用が進むだけでなく、より洗練された、接続された、患者中心のソリューションへと市場が進化しています。

調査対象企業の例（全38件）

• Abbott
• Ascensia Diabetes Care Holdings AG.
• Braun Melsungen AG
• DiaMonTech GmbH
• Dexcom, Inc.
• Hoffmann-La Roche Ltd.
• Lifespan Inc.
• Medtronic
• Sanofi
• Terumo Medical Corporation

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Blood Glucose Meters Market to Reach US$50.1 Billion by 2030

The global market for Blood Glucose Meters estimated at US$31.8 Billion in the year 2023, is expected to reach US$50.1 Billion by 2030, growing at a CAGR of 6.7% over the analysis period 2023-2030. Self-Monitoring Blood Glucose Meters, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$36.8 Billion by the end of the analysis period. Growth in the Continuous Blood Glucose Meters segment is estimated at 7.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$8.6 Billion While China is Forecast to Grow at 10.8% CAGR

The Blood Glucose Meters market in the U.S. is estimated at US$8.6 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$11.4 Billion by the year 2030 trailing a CAGR of 10.8% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.5% and 7.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.8% CAGR.

Global Blood Glucose Meters Market - Key Trends and Drivers Summarized

Why Are Blood Glucose Meters Indispensable in Diabetes Management?

Blood glucose meters are compact, portable medical devices designed to measure and monitor blood sugar levels, providing critical information for individuals managing diabetes. The primary components of a blood glucose meter include a lancet device, test strips, and the digital meter itself. The process begins by using the lancet to prick the fingertip, producing a small drop of blood that is then applied to a test strip. The strip, coated with enzymes like glucose oxidase or glucose dehydrogenase, reacts with the blood sample, generating an electrical signal proportional to the glucose concentration in the blood. This signal is transmitted to the meter, which calculates and displays the blood glucose level in milligrams per deciliter (mg/dL) or millimoles per liter (mmol/L), depending on regional standards. Modern blood glucose meters use advanced biosensing technologies, such as electrochemical and optical sensors, to enhance the accuracy and speed of readings, often delivering results within seconds. Additionally, many meters are equipped with features like memory storage, data tracking, and Bluetooth connectivity, allowing users to store and share their glucose readings with healthcare professionals for more comprehensive diabetes management. Continuous developments in sensor technology and miniaturization have enabled manufacturers to produce meters that require smaller blood samples, minimizing discomfort and making frequent testing more convenient.

Why Are Blood Glucose Meters Essential for Diabetes Care?

Blood glucose meters are crucial for diabetes care because they provide real-time insights into an individual’s blood sugar levels, enabling proactive management of the condition and reducing the risk of complications. Diabetes is a chronic condition characterized by impaired insulin production or utilization, leading to elevated blood glucose levels that can result in serious health issues such as cardiovascular disease, neuropathy, kidney damage, and vision impairment if left unmanaged. Regular monitoring of blood glucose levels is therefore vital for individuals with diabetes to maintain target ranges and prevent both hyperglycemia (high blood sugar) and hypoglycemia (low blood sugar). Blood glucose meters empower users to track their glucose patterns and understand how various factors like food intake, physical activity, stress, and medications affect their blood sugar levels. This knowledge allows for timely adjustments in insulin doses, dietary choices, and lifestyle habits, promoting better glycemic control and reducing the likelihood of long-term complications. Additionally, blood glucose meters are indispensable for patients on intensive insulin therapy, as they provide the necessary data to fine-tune insulin dosages and timing. For healthcare providers, these devices offer a reliable means of monitoring patient progress and making evidence-based decisions regarding treatment plans. The introduction of smart glucose meters with digital integration has further enhanced the role of these devices, allowing seamless sharing of glucose data with healthcare teams and supporting telehealth initiatives.

What Innovations Are Shaping the Future of Blood Glucose Meters?

Recent innovations are transforming the landscape of blood glucose monitoring by making devices more accurate, less invasive, and more integrated with digital health platforms. One of the most notable advancements is the development of continuous glucose monitoring (CGM) systems, which provide real-time glucose readings throughout the day and night using a small sensor placed under the skin. CGM systems eliminate the need for frequent finger pricks and offer a more comprehensive view of glucose trends, alerting users to potential highs and lows before they occur. Additionally, the integration of smart technology in traditional blood glucose meters is enhancing functionality and user experience. Smart meters equipped with Bluetooth and cloud connectivity allow users to sync their readings to mobile apps, providing detailed analytics, trend visualization, and personalized feedback. Some advanced models are incorporating artificial intelligence (AI) algorithms that analyze glucose data and predict fluctuations, helping users anticipate changes and adjust their management strategies accordingly. Another groundbreaking innovation is the emergence of non-invasive glucose monitoring technologies, such as optical sensors and electromagnetic spectroscopy, which aim to measure glucose levels through the skin or other body fluids without the need for blood samples. Although still in development, these technologies promise to revolutionize blood glucose monitoring by significantly reducing the pain and inconvenience associated with traditional testing methods. Furthermore, the use of disposable micro-needles and laser-based sensors is gaining attention for their ability to reduce the discomfort of blood sampling. Advances in biosensor technology are also enabling the creation of multi-analyte meters that can measure additional biomarkers like ketones or lactate, providing a more holistic view of a patient’s metabolic state.

What Are the Key Drivers of Growth in the Blood Glucose Meter Market?

The growth in the blood glucose meter market is driven by several factors, including the rising global prevalence of diabetes, increasing awareness of self-monitoring practices, and continuous advancements in glucose monitoring technology. One of the primary drivers is the escalating incidence of diabetes, particularly type 2 diabetes, which is linked to lifestyle factors such as obesity, poor diet, and lack of physical activity. According to the International Diabetes Federation, over 537 million adults are currently living with diabetes, and this number is expected to rise significantly in the coming decades. This growing patient population is fueling demand for effective blood glucose monitoring solutions, as regular monitoring is a cornerstone of diabetes management. Another factor contributing to market growth is the increasing emphasis on preventive healthcare and self-management. Governments and healthcare organizations are promoting the use of blood glucose meters as part of broader diabetes education programs to encourage early detection and better disease management, thereby reducing the burden on healthcare systems. Technological advancements, such as the development of smart meters and continuous glucose monitoring systems, are also driving market expansion by making glucose monitoring more accessible, accurate, and user-friendly. These devices offer features like automated data logging, cloud-based sharing, and integration with insulin pumps, supporting more comprehensive diabetes management and improving patient adherence. Additionally, the expansion of telehealth and digital health platforms is creating new opportunities for blood glucose meters, as remote monitoring becomes a more common component of diabetes care. Furthermore, increasing disposable incomes and improving healthcare infrastructure in emerging markets are making advanced blood glucose meters more affordable and accessible to a broader consumer base. The introduction of low-cost models and reimbursement policies for glucose meters and test strips in these regions is further boosting market penetration. Collectively, these factors are driving not only the adoption of blood glucose meters but also the evolution of the market towards more sophisticated, connected, and patient-centric solutions.

Select Competitors (Total 38 Featured) -

• Abbott
• Ascensia Diabetes Care Holdings AG.
• Braun Melsungen AG
• DiaMonTech GmbH
• Dexcom, Inc.
• Hoffmann-La Roche Ltd.
• Lifespan Inc.
• Medtronic
• Sanofi
• Terumo Medical Corporation

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Global Economic Update
  • Blood Glucose Meters - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Prevalence of Diabetes Globally Propels Demand for Blood Glucose Meters
  • Increasing Adoption of Self-Monitoring Devices Expands Addressable Market for Blood Glucose Meters
  • Advances in Continuous Glucose Monitoring (CGM) Technology Drives Growth for Smart Blood Glucose Meters
  • Growing Focus on Preventive Healthcare Accelerates Demand for Home-Based Blood Glucose Monitoring
  • Integration of Wireless and Bluetooth Connectivity Strengthens the Business Case for Digital Blood Glucose Meters
  • Increased Adoption of Telemedicine and Remote Monitoring Expands Market Opportunity for Connected Glucose Meters
  • Advances in Biosensor Technologies Propel Growth in Accuracy and Precision of Blood Glucose Meters
  • Growing Demand for Portable and User-Friendly Devices Here's How It Drives Adoption of Compact Blood Glucose Meters
  • Surge in Demand for Wearable Health Devices Accelerates Growth of Integrated Blood Glucose Monitoring Solutions
  • Expansion of Digital Health Platforms Generates Opportunities for Cloud-Connected Blood Glucose Meters
  • Increasing Prevalence of Childhood Diabetes Expands the Market for Pediatric Blood Glucose Meters
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Recent Past, Current & Future Analysis for Invasive by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 2: World Historic Review for Invasive by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 3: World 16-Year Perspective for Invasive by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 4: World Recent Past, Current & Future Analysis for Non-Invasive by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 5: World Historic Review for Non-Invasive by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 6: World 16-Year Perspective for Non-Invasive by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 7: World Blood Glucose Meters Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Blood Glucose Meters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Blood Glucose Meters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 10: World 16-Year Perspective for Blood Glucose Meters by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Self-Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Self-Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 13: World 16-Year Perspective for Self-Monitoring by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Continuous by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Continuous by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 16: World 16-Year Perspective for Continuous by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 19: World 16-Year Perspective for Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 22: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Personal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Personal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 25: World 16-Year Perspective for Personal by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 28: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Blood Glucose Meters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • TABLE 29: USA Recent Past, Current & Future Analysis for Blood Glucose Meters by Technique - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 30: USA Historic Review for Blood Glucose Meters by Technique - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 31: USA 16-Year Perspective for Blood Glucose Meters by Technique - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • TABLE 32: USA Recent Past, Current & Future Analysis for Blood Glucose Meters by Type - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 33: USA Historic Review for Blood Glucose Meters by Type - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 34: USA 16-Year Perspective for Blood Glucose Meters by Type - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
  • TABLE 35: USA Recent Past, Current & Future Analysis for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 36: USA Historic Review for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 37: USA 16-Year Perspective for Blood Glucose Meters by End-Use - Percentage Breakdown of Value Sales for Clinics, Hospitals, Personal and Other End-Uses for the Years 2014, 2024 & 2030
• CANADA
  • TABLE 38: Canada Recent Past, Current & Future Analysis for Blood Glucose Meters by Technique - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 39: Canada Historic Review for Blood Glucose Meters by Technique - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 40: Canada 16-Year Perspective for Blood Glucose Meters by Technique - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • TABLE 41: Canada Recent Past, Current & Future Analysis for Blood Glucose Meters by Type - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 42: Canada Historic Review for Blood Glucose Meters by Type - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 43: Canada 16-Year Perspective for Blood Glucose Meters by Type - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
  • TABLE 44: Canada Recent Past, Current & Future Analysis for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 45: Canada Historic Review for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 46: Canada 16-Year Perspective for Blood Glucose Meters by End-Use - Percentage Breakdown of Value Sales for Clinics, Hospitals, Personal and Other End-Uses for the Years 2014, 2024 & 2030
• JAPAN
  • Blood Glucose Meters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • TABLE 47: Japan Recent Past, Current & Future Analysis for Blood Glucose Meters by Technique - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 48: Japan Historic Review for Blood Glucose Meters by Technique - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 49: Japan 16-Year Perspective for Blood Glucose Meters by Technique - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • TABLE 50: Japan Recent Past, Current & Future Analysis for Blood Glucose Meters by Type - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 51: Japan Historic Review for Blood Glucose Meters by Type - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 52: Japan 16-Year Perspective for Blood Glucose Meters by Type - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
  • TABLE 53: Japan Recent Past, Current & Future Analysis for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 54: Japan Historic Review for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 55: Japan 16-Year Perspective for Blood Glucose Meters by End-Use - Percentage Breakdown of Value Sales for Clinics, Hospitals, Personal and Other End-Uses for the Years 2014, 2024 & 2030
• CHINA
  • Blood Glucose Meters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • TABLE 56: China Recent Past, Current & Future Analysis for Blood Glucose Meters by Technique - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 57: China Historic Review for Blood Glucose Meters by Technique - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 58: China 16-Year Perspective for Blood Glucose Meters by Technique - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • TABLE 59: China Recent Past, Current & Future Analysis for Blood Glucose Meters by Type - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 60: China Historic Review for Blood Glucose Meters by Type - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 61: China 16-Year Perspective for Blood Glucose Meters by Type - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
  • TABLE 62: China Recent Past, Current & Future Analysis for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 63: China Historic Review for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 64: China 16-Year Perspective for Blood Glucose Meters by End-Use - Percentage Breakdown of Value Sales for Clinics, Hospitals, Personal and Other End-Uses for the Years 2014, 2024 & 2030
• EUROPE
  • Blood Glucose Meters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • TABLE 65: Europe Recent Past, Current & Future Analysis for Blood Glucose Meters by Technique - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 66: Europe Historic Review for Blood Glucose Meters by Technique - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 67: Europe 16-Year Perspective for Blood Glucose Meters by Technique - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • TABLE 68: Europe Recent Past, Current & Future Analysis for Blood Glucose Meters by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 69: Europe Historic Review for Blood Glucose Meters by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 70: Europe 16-Year Perspective for Blood Glucose Meters by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
  • TABLE 71: Europe Recent Past, Current & Future Analysis for Blood Glucose Meters by Type - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 72: Europe Historic Review for Blood Glucose Meters by Type - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 73: Europe 16-Year Perspective for Blood Glucose Meters by Type - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
  • TABLE 74: Europe Recent Past, Current & Future Analysis for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 75: Europe Historic Review for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 76: Europe 16-Year Perspective for Blood Glucose Meters by End-Use - Percentage Breakdown of Value Sales for Clinics, Hospitals, Personal and Other End-Uses for the Years 2014, 2024 & 2030
• FRANCE
  • Blood Glucose Meters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • TABLE 77: France Recent Past, Current & Future Analysis for Blood Glucose Meters by Technique - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 78: France Historic Review for Blood Glucose Meters by Technique - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 79: France 16-Year Perspective for Blood Glucose Meters by Technique - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • TABLE 80: France Recent Past, Current & Future Analysis for Blood Glucose Meters by Type - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 81: France Historic Review for Blood Glucose Meters by Type - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 82: France 16-Year Perspective for Blood Glucose Meters by Type - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
  • TABLE 83: France Recent Past, Current & Future Analysis for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 84: France Historic Review for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 85: France 16-Year Perspective for Blood Glucose Meters by End-Use - Percentage Breakdown of Value Sales for Clinics, Hospitals, Personal and Other End-Uses for the Years 2014, 2024 & 2030
• GERMANY
  • Blood Glucose Meters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • TABLE 86: Germany Recent Past, Current & Future Analysis for Blood Glucose Meters by Technique - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 87: Germany Historic Review for Blood Glucose Meters by Technique - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 88: Germany 16-Year Perspective for Blood Glucose Meters by Technique - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • TABLE 89: Germany Recent Past, Current & Future Analysis for Blood Glucose Meters by Type - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 90: Germany Historic Review for Blood Glucose Meters by Type - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 91: Germany 16-Year Perspective for Blood Glucose Meters by Type - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
  • TABLE 92: Germany Recent Past, Current & Future Analysis for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 93: Germany Historic Review for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 94: Germany 16-Year Perspective for Blood Glucose Meters by End-Use - Percentage Breakdown of Value Sales for Clinics, Hospitals, Personal and Other End-Uses for the Years 2014, 2024 & 2030
• ITALY
  • TABLE 95: Italy Recent Past, Current & Future Analysis for Blood Glucose Meters by Technique - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 96: Italy Historic Review for Blood Glucose Meters by Technique - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 97: Italy 16-Year Perspective for Blood Glucose Meters by Technique - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • TABLE 98: Italy Recent Past, Current & Future Analysis for Blood Glucose Meters by Type - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 99: Italy Historic Review for Blood Glucose Meters by Type - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 100: Italy 16-Year Perspective for Blood Glucose Meters by Type - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
  • TABLE 101: Italy Recent Past, Current & Future Analysis for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 102: Italy Historic Review for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 103: Italy 16-Year Perspective for Blood Glucose Meters by End-Use - Percentage Breakdown of Value Sales for Clinics, Hospitals, Personal and Other End-Uses for the Years 2014, 2024 & 2030
• UNITED KINGDOM
  • Blood Glucose Meters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • TABLE 104: UK Recent Past, Current & Future Analysis for Blood Glucose Meters by Technique - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 105: UK Historic Review for Blood Glucose Meters by Technique - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 106: UK 16-Year Perspective for Blood Glucose Meters by Technique - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • TABLE 107: UK Recent Past, Current & Future Analysis for Blood Glucose Meters by Type - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 108: UK Historic Review for Blood Glucose Meters by Type - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 109: UK 16-Year Perspective for Blood Glucose Meters by Type - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
  • TABLE 110: UK Recent Past, Current & Future Analysis for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 111: UK Historic Review for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 112: UK 16-Year Perspective for Blood Glucose Meters by End-Use - Percentage Breakdown of Value Sales for Clinics, Hospitals, Personal and Other End-Uses for the Years 2014, 2024 & 2030
• SPAIN
  • TABLE 113: Spain Recent Past, Current & Future Analysis for Blood Glucose Meters by Technique - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 114: Spain Historic Review for Blood Glucose Meters by Technique - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 115: Spain 16-Year Perspective for Blood Glucose Meters by Technique - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • TABLE 116: Spain Recent Past, Current & Future Analysis for Blood Glucose Meters by Type - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 117: Spain Historic Review for Blood Glucose Meters by Type - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 118: Spain 16-Year Perspective for Blood Glucose Meters by Type - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
  • TABLE 119: Spain Recent Past, Current & Future Analysis for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 120: Spain Historic Review for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 121: Spain 16-Year Perspective for Blood Glucose Meters by End-Use - Percentage Breakdown of Value Sales for Clinics, Hospitals, Personal and Other End-Uses for the Years 2014, 2024 & 2030
• RUSSIA
  • TABLE 122: Russia Recent Past, Current & Future Analysis for Blood Glucose Meters by Technique - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 123: Russia Historic Review for Blood Glucose Meters by Technique - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 124: Russia 16-Year Perspective for Blood Glucose Meters by Technique - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • TABLE 125: Russia Recent Past, Current & Future Analysis for Blood Glucose Meters by Type - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 126: Russia Historic Review for Blood Glucose Meters by Type - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 127: Russia 16-Year Perspective for Blood Glucose Meters by Type - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
  • TABLE 128: Russia Recent Past, Current & Future Analysis for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 129: Russia Historic Review for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 130: Russia 16-Year Perspective for Blood Glucose Meters by End-Use - Percentage Breakdown of Value Sales for Clinics, Hospitals, Personal and Other End-Uses for the Years 2014, 2024 & 2030
• REST OF EUROPE
  • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Blood Glucose Meters by Technique - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 132: Rest of Europe Historic Review for Blood Glucose Meters by Technique - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 133: Rest of Europe 16-Year Perspective for Blood Glucose Meters by Technique - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Blood Glucose Meters by Type - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 135: Rest of Europe Historic Review for Blood Glucose Meters by Type - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 136: Rest of Europe 16-Year Perspective for Blood Glucose Meters by Type - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
  • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 138: Rest of Europe Historic Review for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 139: Rest of Europe 16-Year Perspective for Blood Glucose Meters by End-Use - Percentage Breakdown of Value Sales for Clinics, Hospitals, Personal and Other End-Uses for the Years 2014, 2024 & 2030
• ASIA-PACIFIC
  • Blood Glucose Meters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Blood Glucose Meters by Technique - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 141: Asia-Pacific Historic Review for Blood Glucose Meters by Technique - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 142: Asia-Pacific 16-Year Perspective for Blood Glucose Meters by Technique - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Blood Glucose Meters by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 144: Asia-Pacific Historic Review for Blood Glucose Meters by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 145: Asia-Pacific 16-Year Perspective for Blood Glucose Meters by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
  • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Blood Glucose Meters by Type - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 147: Asia-Pacific Historic Review for Blood Glucose Meters by Type - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 148: Asia-Pacific 16-Year Perspective for Blood Glucose Meters by Type - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
  • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 150: Asia-Pacific Historic Review for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 151: Asia-Pacific 16-Year Perspective for Blood Glucose Meters by End-Use - Percentage Breakdown of Value Sales for Clinics, Hospitals, Personal and Other End-Uses for the Years 2014, 2024 & 2030
• AUSTRALIA
  • Blood Glucose Meters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
  • TABLE 152: Australia Recent Past, Current & Future Analysis for Blood Glucose Meters by Technique - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 153: Australia Historic Review for Blood Glucose Meters by Technique - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 154: Australia 16-Year Perspective for Blood Glucose Meters by Technique - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • TABLE 155: Australia Recent Past, Current & Future Analysis for Blood Glucose Meters by Type - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 156: Australia Historic Review for Blood Glucose Meters by Type - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 157: Australia 16-Year Perspective for Blood Glucose Meters by Type - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
  • TABLE 158: Australia Recent Past, Current & Future Analysis for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 159: Australia Historic Review for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 160: Australia 16-Year Perspective for Blood Glucose Meters by End-Use - Percentage Breakdown of Value Sales for Clinics, Hospitals, Personal and Other End-Uses for the Years 2014, 2024 & 2030
• INDIA
  • Blood Glucose Meters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
  • TABLE 161: India Recent Past, Current & Future Analysis for Blood Glucose Meters by Technique - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 162: India Historic Review for Blood Glucose Meters by Technique - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 163: India 16-Year Perspective for Blood Glucose Meters by Technique - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • TABLE 164: India Recent Past, Current & Future Analysis for Blood Glucose Meters by Type - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 165: India Historic Review for Blood Glucose Meters by Type - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 166: India 16-Year Perspective for Blood Glucose Meters by Type - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
  • TABLE 167: India Recent Past, Current & Future Analysis for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 168: India Historic Review for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 169: India 16-Year Perspective for Blood Glucose Meters by End-Use - Percentage Breakdown of Value Sales for Clinics, Hospitals, Personal and Other End-Uses for the Years 2014, 2024 & 2030
• SOUTH KOREA
  • TABLE 170: South Korea Recent Past, Current & Future Analysis for Blood Glucose Meters by Technique - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 171: South Korea Historic Review for Blood Glucose Meters by Technique - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 172: South Korea 16-Year Perspective for Blood Glucose Meters by Technique - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • TABLE 173: South Korea Recent Past, Current & Future Analysis for Blood Glucose Meters by Type - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 174: South Korea Historic Review for Blood Glucose Meters by Type - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 175: South Korea 16-Year Perspective for Blood Glucose Meters by Type - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
  • TABLE 176: South Korea Recent Past, Current & Future Analysis for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 177: South Korea Historic Review for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 178: South Korea 16-Year Perspective for Blood Glucose Meters by End-Use - Percentage Breakdown of Value Sales for Clinics, Hospitals, Personal and Other End-Uses for the Years 2014, 2024 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Blood Glucose Meters by Technique - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 180: Rest of Asia-Pacific Historic Review for Blood Glucose Meters by Technique - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 181: Rest of Asia-Pacific 16-Year Perspective for Blood Glucose Meters by Technique - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Blood Glucose Meters by Type - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 183: Rest of Asia-Pacific Historic Review for Blood Glucose Meters by Type - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 184: Rest of Asia-Pacific 16-Year Perspective for Blood Glucose Meters by Type - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
  • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 186: Rest of Asia-Pacific Historic Review for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 187: Rest of Asia-Pacific 16-Year Perspective for Blood Glucose Meters by End-Use - Percentage Breakdown of Value Sales for Clinics, Hospitals, Personal and Other End-Uses for the Years 2014, 2024 & 2030
• LATIN AMERICA
  • Blood Glucose Meters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
  • TABLE 188: Latin America Recent Past, Current & Future Analysis for Blood Glucose Meters by Technique - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 189: Latin America Historic Review for Blood Glucose Meters by Technique - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 190: Latin America 16-Year Perspective for Blood Glucose Meters by Technique - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • TABLE 191: Latin America Recent Past, Current & Future Analysis for Blood Glucose Meters by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 192: Latin America Historic Review for Blood Glucose Meters by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 193: Latin America 16-Year Perspective for Blood Glucose Meters by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
  • TABLE 194: Latin America Recent Past, Current & Future Analysis for Blood Glucose Meters by Type - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 195: Latin America Historic Review for Blood Glucose Meters by Type - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 196: Latin America 16-Year Perspective for Blood Glucose Meters by Type - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
  • TABLE 197: Latin America Recent Past, Current & Future Analysis for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 198: Latin America Historic Review for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 199: Latin America 16-Year Perspective for Blood Glucose Meters by End-Use - Percentage Breakdown of Value Sales for Clinics, Hospitals, Personal and Other End-Uses for the Years 2014, 2024 & 2030
• ARGENTINA
  • TABLE 200: Argentina Recent Past, Current & Future Analysis for Blood Glucose Meters by Technique - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 201: Argentina Historic Review for Blood Glucose Meters by Technique - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 202: Argentina 16-Year Perspective for Blood Glucose Meters by Technique - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • TABLE 203: Argentina Recent Past, Current & Future Analysis for Blood Glucose Meters by Type - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 204: Argentina Historic Review for Blood Glucose Meters by Type - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 205: Argentina 16-Year Perspective for Blood Glucose Meters by Type - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
  • TABLE 206: Argentina Recent Past, Current & Future Analysis for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 207: Argentina Historic Review for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 208: Argentina 16-Year Perspective for Blood Glucose Meters by End-Use - Percentage Breakdown of Value Sales for Clinics, Hospitals, Personal and Other End-Uses for the Years 2014, 2024 & 2030
• BRAZIL
  • TABLE 209: Brazil Recent Past, Current & Future Analysis for Blood Glucose Meters by Technique - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 210: Brazil Historic Review for Blood Glucose Meters by Technique - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 211: Brazil 16-Year Perspective for Blood Glucose Meters by Technique - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • TABLE 212: Brazil Recent Past, Current & Future Analysis for Blood Glucose Meters by Type - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 213: Brazil Historic Review for Blood Glucose Meters by Type - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 214: Brazil 16-Year Perspective for Blood Glucose Meters by Type - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
  • TABLE 215: Brazil Recent Past, Current & Future Analysis for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 216: Brazil Historic Review for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 217: Brazil 16-Year Perspective for Blood Glucose Meters by End-Use - Percentage Breakdown of Value Sales for Clinics, Hospitals, Personal and Other End-Uses for the Years 2014, 2024 & 2030
• MEXICO
  • TABLE 218: Mexico Recent Past, Current & Future Analysis for Blood Glucose Meters by Technique - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 219: Mexico Historic Review for Blood Glucose Meters by Technique - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 220: Mexico 16-Year Perspective for Blood Glucose Meters by Technique - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • TABLE 221: Mexico Recent Past, Current & Future Analysis for Blood Glucose Meters by Type - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 222: Mexico Historic Review for Blood Glucose Meters by Type - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 223: Mexico 16-Year Perspective for Blood Glucose Meters by Type - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
  • TABLE 224: Mexico Recent Past, Current & Future Analysis for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 225: Mexico Historic Review for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 226: Mexico 16-Year Perspective for Blood Glucose Meters by End-Use - Percentage Breakdown of Value Sales for Clinics, Hospitals, Personal and Other End-Uses for the Years 2014, 2024 & 2030
• REST OF LATIN AMERICA
  • TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Blood Glucose Meters by Technique - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 228: Rest of Latin America Historic Review for Blood Glucose Meters by Technique - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 229: Rest of Latin America 16-Year Perspective for Blood Glucose Meters by Technique - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Blood Glucose Meters by Type - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 231: Rest of Latin America Historic Review for Blood Glucose Meters by Type - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 232: Rest of Latin America 16-Year Perspective for Blood Glucose Meters by Type - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
  • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 234: Rest of Latin America Historic Review for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 235: Rest of Latin America 16-Year Perspective for Blood Glucose Meters by End-Use - Percentage Breakdown of Value Sales for Clinics, Hospitals, Personal and Other End-Uses for the Years 2014, 2024 & 2030
• MIDDLE EAST
  • Blood Glucose Meters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
  • TABLE 236: Middle East Recent Past, Current & Future Analysis for Blood Glucose Meters by Technique - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 237: Middle East Historic Review for Blood Glucose Meters by Technique - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 238: Middle East 16-Year Perspective for Blood Glucose Meters by Technique - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • TABLE 239: Middle East Recent Past, Current & Future Analysis for Blood Glucose Meters by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 240: Middle East Historic Review for Blood Glucose Meters by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 241: Middle East 16-Year Perspective for Blood Glucose Meters by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
  • TABLE 242: Middle East Recent Past, Current & Future Analysis for Blood Glucose Meters by Type - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 243: Middle East Historic Review for Blood Glucose Meters by Type - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 244: Middle East 16-Year Perspective for Blood Glucose Meters by Type - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
  • TABLE 245: Middle East Recent Past, Current & Future Analysis for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 246: Middle East Historic Review for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 247: Middle East 16-Year Perspective for Blood Glucose Meters by End-Use - Percentage Breakdown of Value Sales for Clinics, Hospitals, Personal and Other End-Uses for the Years 2014, 2024 & 2030
• IRAN
  • TABLE 248: Iran Recent Past, Current & Future Analysis for Blood Glucose Meters by Technique - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 249: Iran Historic Review for Blood Glucose Meters by Technique - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 250: Iran 16-Year Perspective for Blood Glucose Meters by Technique - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • TABLE 251: Iran Recent Past, Current & Future Analysis for Blood Glucose Meters by Type - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 252: Iran Historic Review for Blood Glucose Meters by Type - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 253: Iran 16-Year Perspective for Blood Glucose Meters by Type - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
  • TABLE 254: Iran Recent Past, Current & Future Analysis for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 255: Iran Historic Review for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 256: Iran 16-Year Perspective for Blood Glucose Meters by End-Use - Percentage Breakdown of Value Sales for Clinics, Hospitals, Personal and Other End-Uses for the Years 2014, 2024 & 2030
• ISRAEL
  • TABLE 257: Israel Recent Past, Current & Future Analysis for Blood Glucose Meters by Technique - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 258: Israel Historic Review for Blood Glucose Meters by Technique - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 259: Israel 16-Year Perspective for Blood Glucose Meters by Technique - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • TABLE 260: Israel Recent Past, Current & Future Analysis for Blood Glucose Meters by Type - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 261: Israel Historic Review for Blood Glucose Meters by Type - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 262: Israel 16-Year Perspective for Blood Glucose Meters by Type - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
  • TABLE 263: Israel Recent Past, Current & Future Analysis for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 264: Israel Historic Review for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 265: Israel 16-Year Perspective for Blood Glucose Meters by End-Use - Percentage Breakdown of Value Sales for Clinics, Hospitals, Personal and Other End-Uses for the Years 2014, 2024 & 2030
• SAUDI ARABIA
  • TABLE 266: Saudi Arabia Recent Past, Current & Future Analysis for Blood Glucose Meters by Technique - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 267: Saudi Arabia Historic Review for Blood Glucose Meters by Technique - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 268: Saudi Arabia 16-Year Perspective for Blood Glucose Meters by Technique - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Blood Glucose Meters by Type - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 270: Saudi Arabia Historic Review for Blood Glucose Meters by Type - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 271: Saudi Arabia 16-Year Perspective for Blood Glucose Meters by Type - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
  • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 273: Saudi Arabia Historic Review for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 274: Saudi Arabia 16-Year Perspective for Blood Glucose Meters by End-Use - Percentage Breakdown of Value Sales for Clinics, Hospitals, Personal and Other End-Uses for the Years 2014, 2024 & 2030
• UNITED ARAB EMIRATES
  • TABLE 275: UAE Recent Past, Current & Future Analysis for Blood Glucose Meters by Technique - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 276: UAE Historic Review for Blood Glucose Meters by Technique - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 277: UAE 16-Year Perspective for Blood Glucose Meters by Technique - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • TABLE 278: UAE Recent Past, Current & Future Analysis for Blood Glucose Meters by Type - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 279: UAE Historic Review for Blood Glucose Meters by Type - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 280: UAE 16-Year Perspective for Blood Glucose Meters by Type - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
  • TABLE 281: UAE Recent Past, Current & Future Analysis for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 282: UAE Historic Review for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 283: UAE 16-Year Perspective for Blood Glucose Meters by End-Use - Percentage Breakdown of Value Sales for Clinics, Hospitals, Personal and Other End-Uses for the Years 2014, 2024 & 2030
• REST OF MIDDLE EAST
  • TABLE 284: Rest of Middle East Recent Past, Current & Future Analysis for Blood Glucose Meters by Technique - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 285: Rest of Middle East Historic Review for Blood Glucose Meters by Technique - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 286: Rest of Middle East 16-Year Perspective for Blood Glucose Meters by Technique - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Blood Glucose Meters by Type - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 288: Rest of Middle East Historic Review for Blood Glucose Meters by Type - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 289: Rest of Middle East 16-Year Perspective for Blood Glucose Meters by Type - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
  • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 291: Rest of Middle East Historic Review for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 292: Rest of Middle East 16-Year Perspective for Blood Glucose Meters by End-Use - Percentage Breakdown of Value Sales for Clinics, Hospitals, Personal and Other End-Uses for the Years 2014, 2024 & 2030
• AFRICA
  • Blood Glucose Meters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
  • TABLE 293: Africa Recent Past, Current & Future Analysis for Blood Glucose Meters by Technique - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 294: Africa Historic Review for Blood Glucose Meters by Technique - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 295: Africa 16-Year Perspective for Blood Glucose Meters by Technique - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • TABLE 296: Africa Recent Past, Current & Future Analysis for Blood Glucose Meters by Type - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 297: Africa Historic Review for Blood Glucose Meters by Type - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 298: Africa 16-Year Perspective for Blood Glucose Meters by Type - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
  • TABLE 299: Africa Recent Past, Current & Future Analysis for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 300: Africa Historic Review for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 301: Africa 16-Year Perspective for Blood Glucose Meters by End-Use - Percentage Breakdown of Value Sales for Clinics, Hospitals, Personal and Other End-Uses for the Years 2014, 2024 & 2030

IV. COMPETITION